1
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21616 |
L-006235
L 006235 |
Cysteine Protease | Proteases/Proteasome |
L-006235 是一种口服有活性的、可逆的cathepsin K 选择性抑制剂,在骨吸收试验中的IC50值为 5 nM。它能够抑制胶原蛋白降解,并较少骨质流失。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06090 |
SARS-CoV-2 Nucleocapsid Protein (D3L & S235F, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (D3L & S235F, His) is expressed in E. coli expression system. The predicted molecular weight is 46.5 kDa and the accession number is P0DTC9. | |||
TMPY-06089 |
SARS-CoV-2 Nucleocapsid Protein (D3L & R203K & G204R & S235F, His)
|
SARS-CoV-2 | E. coli |
SARS-CoV-2 Nucleocapsid Protein (D3L & R203K & G204R & S235F, His) is expressed in E. coli expression system. The predicted molecular weight is 46.6 kDa and the accession number is P0DTC9. |